サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1564084

スライド全体のイメージングの世界市場

Whole Slide Imaging
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
スライド全体のイメージングの世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

スライド全体のイメージングの世界市場は2030年までに29億米ドルに達する見込み

2023年に8億9,070万米ドルと推定されるスライド全体のイメージングの世界市場は、2023年から2030年にかけてCAGR 18.3％で成長し、2030年には29億米ドルに達すると予測されます。本レポートで分析しているセグメントの1つであるスライド全体のイメージングハードウェアは、CAGR 18.9％を記録し、分析期間終了時には15億米ドルに達すると予測されています。スライド全体のイメージングソフトウェア分野の成長率は、分析期間中CAGR 17.8％と推定されます。

米国市場は2億4,150万米ドルと推定、中国はCAGR16.9％で成長予測

米国のスライド全体のイメージング市場は、2023年に2億4,150万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR16.9%で推移し、2030年には4億2,460万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ16.5％と15.6％と予測されています。欧州では、ドイツがCAGR約13.0%で成長すると予測されています。

世界のスライド全体のイメージング市場- 主要動向と促進要因のまとめ

なぜスライド全体のイメージングが病理・診断業務を変革するのか？

スライド全体のイメージング（WSI）は、組織スライド全体のデジタル化を可能にし、病理スライドの高解像度検査、保存、共有を可能にすることで、病理学および診断の分野に革命をもたらしています。この技術により、遠隔診察、デジタルアーカイブ、AI主導の分析が容易になり、腫瘍学、血液学、感染症における診断の精度と効率が向上します。診断ワークフローの改善、テレパソロジー、人工知能の統合の必要性によってデジタルパソロジーの採用が増加していることが、WSIシステムの需要を促進しています。個別化医療の台頭と、正確で再現可能な診断データの必要性により、WSIは現代のヘルスケアにおいて極めて重要なツールとなりつつあります。

技術の進歩はどのようにスライド全体のイメージングシステムを強化しているのか？

イメージングハードウェア、データ管理、人工知能の技術的進歩は、スライド全体のイメージングシステムの機能と応用を大幅に向上させています。より高い解像度と焦点深度を持つ高速スキャナーの開発により、組織の形態や病理をより正確かつ詳細に可視化することが可能になりました。データ圧縮とクラウドストレージソリューションの革新は、大規模な画像データセットの取り扱い、保存、検索を改善し、病理検査室でのシームレスなデジタルワークフローを促進しています。さらに、AIと機械学習アルゴリズムの統合により、自動画像解析、パターン認識、予測診断が可能になり、病理医の作業負担が軽減され、診断精度が向上しています。これらの進歩は、臨床診断、研究、教育におけるWSIの採用を促進しています。

スライド全体のイメージング市場の課題と機会は？

スライド全体のイメージング市場は、WSIシステムの初期コストの高さ、データ管理の複雑さ、デジタル病理プラットフォーム間の標準化と相互運用性の必要性など、いくつかの課題に直面しています。さらに、規制上のハードルやデジタル病理システムの臨床使用に対する検証の必要性が、採用を遅らせる可能性があります。しかし、これらの課題は成長と革新の機会にもなります。高画質画像、既存の検査インフラとの容易な統合、堅牢なデータ管理機能を提供する、費用対効果に優れ拡張性のあるWSIソリューションの開発は、臨床と研究の両方の場面で採用を促進するのに役立ちます。セカンドオピニオンや専門知識の必要性からテレパソロジーや遠隔診断の需要が高まっており、シームレスなデジタル診察やコラボレーションをサポートするWSIシステムに新たな成長機会が生まれています。さらに、AI主導の診断と精密医療への注目の高まりが、臨床的意思決定のための信頼性と再現性の高いデータを提供する高度なWSIソリューションの必要性を高めています。

スライド全体のイメージング市場の成長の原動力は？

スライド全体のイメージング市場の成長は、デジタルパソロジーの採用の増加、遠隔病理診断と遠隔診断の需要の高まり、イメージングハードウェア、データ管理、AI主導の分析における技術進歩など、いくつかの要因によってもたらされます。病理診断における診断精度の向上、効率化、共同作業の必要性が、臨床・研究現場におけるWSIシステムの市場需要を大幅に押し上げています。高解像度イメージング、クラウドストレージ、AIベースの分析における技術革新は、WSIシステムの機能と拡張性を高め、病院、研究機関、診断ラボにとってより魅力的なものとなっています。また、個別化医療の拡大とデジタルヘルスケア変革の重視の高まりも、利害関係者が診断ワークフローと患者の転帰を向上させる高度なデジタル病理ツールを求めていることから、市場成長の原動力となっています。

調査対象企業の例（注目の47社）

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP15632

Global Whole Slide Imaging Market to Reach US$2.9 Billion by 2030

The global market for Whole Slide Imaging estimated at US$890.7 Million in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2023-2030. Whole Slide Imaging Hardware, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Whole Slide Imaging Software segment is estimated at 17.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$241.5 Million While China is Forecast to Grow at 16.9% CAGR

The Whole Slide Imaging market in the U.S. is estimated at US$241.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$424.6 Million by the year 2030 trailing a CAGR of 16.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.5% and 15.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Whole Slide Imaging Market - Key Trends & Drivers Summarized

Why Is Whole Slide Imaging Transforming Pathology and Diagnostic Practices?

Whole Slide Imaging (WSI) is revolutionizing the field of pathology and diagnostic practices by enabling the digitization of entire histological slides, allowing for high-resolution examination, storage, and sharing of pathology slides. This technology facilitates remote consultations, digital archiving, and AI-driven analysis, enhancing the accuracy and efficiency of diagnostics in oncology, hematology, and infectious diseases. The increasing adoption of digital pathology, driven by the need for improved diagnostic workflows, telepathology, and the integration of artificial intelligence, is propelling the demand for WSI systems. With the rise of personalized medicine and the need for precise and reproducible diagnostic data, WSI is becoming a crucial tool in modern healthcare.

How Are Technological Advancements Enhancing Whole Slide Imaging Systems?

Technological advancements in imaging hardware, data management, and artificial intelligence are significantly enhancing the capabilities and applications of whole slide imaging systems. The development of high-speed scanners with higher resolution and depth of focus is enabling more accurate and detailed visualization of tissue morphology and pathology. Innovations in data compression and cloud storage solutions are improving the handling, storage, and retrieval of large image datasets, facilitating seamless digital workflows in pathology labs. Additionally, the integration of AI and machine learning algorithms is enabling automated image analysis, pattern recognition, and predictive diagnostics, reducing the workload on pathologists and increasing diagnostic accuracy. These advancements are driving the adoption of WSI in clinical diagnostics, research, and education.

What Are the Challenges and Opportunities in the Whole Slide Imaging Market?

The whole slide imaging market faces several challenges, including high initial costs of WSI systems, data management complexities, and the need for standardization and interoperability across digital pathology platforms. Additionally, regulatory hurdles and the need for validation of digital pathology systems for clinical use can slow down adoption. However, these challenges also present opportunities for growth and innovation. The development of cost-effective and scalable WSI solutions that offer high-quality imaging, easy integration with existing lab infrastructure, and robust data management capabilities can help drive adoption in both clinical and research settings. The increasing demand for telepathology and remote diagnostics, driven by the need for second opinions and specialized expertise, is creating new growth opportunities for WSI systems that support seamless digital consultation and collaboration. Moreover, the rising focus on AI-driven diagnostics and precision medicine is driving the need for advanced WSI solutions that provide reliable and reproducible data for clinical decision-making.

What Is Driving the Growth of the Whole Slide Imaging Market?

The growth in the Whole Slide Imaging market is driven by several factors, including the increasing adoption of digital pathology, rising demand for telepathology and remote diagnostics, and technological advancements in imaging hardware, data management, and AI-driven analysis. The need for improved diagnostic accuracy, efficiency, and collaboration in pathology is significantly boosting market demand for WSI systems in clinical and research settings. Technological innovations in high-resolution imaging, cloud storage, and AI-based analytics are enhancing the capabilities and scalability of WSI systems, making them more attractive to hospitals, research institutes, and diagnostic labs. The expansion of personalized medicine and the growing emphasis on digital healthcare transformation are also driving market growth as stakeholders seek advanced digital pathology tools to enhance diagnostic workflows and patient outcomes.

Select Competitors (Total 47 Featured) -

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Whole Slide Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Digital Pathology Solutions Drives Whole Slide Imaging Market
    • Technological Advancements in Imaging and Analysis Propel Market Growth
    • Increased Adoption in Clinical Diagnostics Enhances Whole Slide Imaging Utilization
    • Growth in Cancer Research Necessitates Efficient Whole Slide Imaging Solutions
    • Integration of AI and Machine Learning in Image Analysis Expands Capabilities
    • Global Expansion of Telepathology Services Amplifies Whole Slide Imaging Demand
    • Regulatory and Compliance Requirements Influence Whole Slide Imaging Adoption
    • Developments in High-Throughput Scanning Technologies Boost Market Efficiency
    • Rising Healthcare Expenditure Worldwide Sustains Investment in Digital Imaging
    • Technological Convergence in Healthcare IT Systems Promotes Interoperability
    • Data Management and Storage Challenges Drive Solutions in Digital Pathology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Slide Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Telepathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Telepathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cytopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Cytopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hematopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Hematopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: USA 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Canada 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • JAPAN
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • CHINA
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: China 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • EUROPE
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • FRANCE
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: France 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • GERMANY
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Germany 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Italy 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • UNITED KINGDOM
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: UK 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Rest of World 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030

IV. COMPETITION